Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges

Nonalcoholic fatty liver disease (NAFLD) is increasing in prevalence in concert with the global epidemic of obesity and is being diagnosed at increasingly younger ages. The unique histologic features and early presentation of disease in pediatrics suggest that children and adults may differ with regard to etiopathogenesis, with children displaying a greater vulnerability to genetic and environmental factors. Of significant relevance to pediatrics, in utero and perinatal stressors may alter the lifelong health trajectory of a child, increasing the risk of NAFLD and other cardiometabolic diseases. The development and progression of disease in childhood is likely to carry increased risk of long-term morbidity. Novel biomarkers and therapeutic agents are needed to avoid the otherwise inevitable health and societal consequences of this rapidly expanding pediatric population.

• Publication year

  2020

• Venue

  Gastroenterology

• Publication date

  2020-05-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1053/J.GASTRO.2020.01.048
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Low Free Sugar Diet in Adolescents With Nonalcoholic Fatty Liver Disease-Reply.

  2019cited by this paper
• Sex Differences in Nonalcoholic Fatty Liver Disease: State of the Art and Identification of Research Gaps

  2019cited by this paper
• Effect of a Low Free Sugar Diet vs Usual Diet on Nonalcoholic Fatty Liver Disease in Adolescent Boys: A Randomized Clinical Trial

  2019cited by this paper
• Obstructive Sleep Apnea and the Liver.

  2019cited by this paper
• Role for diet in normal gut barrier function: developing guidance within the framework of food-labeling regulations

  2019cited by this paper
• Evaluations of Lifestyle, Dietary, and Pharmacologic Treatments for Pediatric Nonalcoholic Fatty Liver Disease: A Systematic Review.

  2019cited by this paper
• 17‐Beta Hydroxysteroid Dehydrogenase 13 Is a Hepatic Retinol Dehydrogenase Associated With Histological Features of Nonalcoholic Fatty Liver Disease

  2019cited by this paper
• Noninvasive Assessment of Liver Disease in Patients With Nonalcoholic Fatty Liver Disease.

  2019cited by this paper
• Microbiome Signatures Associated with Steatohepatitis and Moderate to Severe Fibrosis in Children With Nonalcoholic Fatty Liver Disease.

  2019cited by this paper
• A Systematic Review of NAFLD-Associated Extrahepatic Disorders in Youths

  2019cited by this paper
• Factors to Consider in Development of Drugs for Pediatric Nonalcoholic Fatty Liver Disease.

  2019cited by this paper
• The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases

  2018cited by this paper
• Prevalence of Suspected Nonalcoholic Fatty Liver Disease in Lean Adolescents in the United States

  2018cited by this paper
• Obesogenic Endocrine Disrupting Chemicals: Identifying Knowledge Gaps.

  2018cited by this paper
• Diagnostic Performance of Transient Elastography for Liver Fibrosis in Children: A Systematic Review and Meta-Analysis.

  2018cited by this paper
• Hypoxic Signaling and Cholesterol Lipotoxicity in Fatty Liver Disease Progression

  2018cited by this paper
• The role of the microbiome in NAFLD and NASH

  2018cited by this paper
• Clinically Actionable Hypercholesterolemia and Hypertriglyceridemia in Children with Nonalcoholic Fatty Liver Disease

  2018cited by this paper
• Multiomics biomarkers for the prediction of nonalcoholic fatty liver disease severity

  2018cited by this paper
• Pediatric Nonalcoholic Fatty Liver Disease in New York City: An Autopsy Study

  2018cited by this paper
• NASH Leading Cause of Liver Transplant in Women: Updated Analysis of Indications For Liver Transplant and Ethnic and Gender Variances

  2018cited by this paper
• Performance of fibrosis prediction scores in paediatric non‐alcoholic fatty liver disease

  2018cited by this paper
• The rs626283 Variant in the MBOAT7 Gene is Associated with Insulin Resistance and Fatty Liver in Caucasian Obese Youth

  2018cited by this paper
• Imbalance in gut microbes from babies born to obese mothers increases gut permeability and myeloid cell adaptations that provoke obesity and NAFLD

  2018cited by this paper
• NAFLD AND NASH: Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention

  2018cited by this paper
• Carbohydrates and diet patterns in nonalcoholic fatty liver disease in children and adolescents

  2018cited by this paper
• Treating Obstructive Sleep Apnea and Chronic Intermittent Hypoxia Improves the Severity of Nonalcoholic Fatty Liver Disease in Children

  2018cited by this paper
• The diagnostic performance of shear-wave elastography for liver fibrosis in children and adolescents: A systematic review and diagnostic meta-analysis

  2018cited by this paper
• Bisphenol a increases risk for presumed non-alcoholic fatty liver disease in Hispanic adolescents in NHANES 2003–2010

  2018cited by this paper
• Validation of Transient Elastography Cut Points to Assess Advanced Liver Fibrosis in Children and Young Adults: The Boston Children's Hospital Experience

  2018cited by this paper
• The gut–liver axis and the intersection with the microbiome

  2018cited by this paper
• The presence and severity of nonalcoholic steatohepatitis is associated with specific changes in circulating bile acids

  2018cited by this paper
• Current and future therapeutic regimens for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

  2018cited by this paper
• The gut microbiota in infants of obese mothers increases inflammation and susceptibility to NAFLD

  2018cited by this paper
• In Children With Nonalcoholic Fatty Liver Disease, Zone 1 Steatosis Is Associated With Advanced Fibrosis

  2017cited by this paper
• Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter

  2017cited by this paper
• Low and High Birth Weights Are Risk Factors for Nonalcoholic Fatty Liver Disease in Children.

  2017cited by this paper
• Magnetic resonance elastography measured shear stiffness as a biomarker of fibrosis in pediatric nonalcoholic fatty liver disease

  2017cited by this paper
• Bile acid control of metabolism and inflammation in obesity, type 2 diabetes, dyslipidemia and NAFLD.

  2017cited by this paper
• Liver Stiffness in Pediatric Patients with Fatty Liver Disease: Diagnostic Accuracy and Reproducibility of Shear-Wave Elastography.

  2017cited by this paper
• A Branched-Chain Amino Acid-Related Metabolic Signature Characterizes Obese Adolescents with Non-Alcoholic Fatty Liver Disease

  2017cited by this paper
• The Benefit of Sleeve Gastrectomy in Obese Adolescents on Nonalcoholic Steatohepatitis and Hepatic Fibrosis

  2017cited by this paper
• Developmental origins of NAFLD: a womb with a clue

  2017cited by this paper
• Fibrosis stage but not NASH predicts mortality and time to development of severe liver disease in biopsy-proven NAFLD.

  2017cited by this paper
• Effects of Dietary Fructose Restriction on Liver Fat, De Novo Lipogenesis, and Insulin Kinetics in Children With Obesity.

  2017cited by this paper
• The Effects of Exercise on Abdominal Fat and Liver Enzymes in Pediatric Obesity: A Systematic Review and Meta-Analysis

  2017cited by this paper
• Genome‐Wide Associations Related to Hepatic Histology in Nonalcoholic Fatty Liver Disease in Hispanic Boys

  2017cited by this paper
• Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis

  2017cited by this paper
• Increased risk of mortality by fibrosis stage in nonalcoholic fatty liver disease: Systematic review and meta‐analysis

  2017cited by this paper
• Gut microbiota profiling of pediatric nonalcoholic fatty liver disease and obese patients unveiled by an integrated meta‐omics‐based approach

  2017cited by this paper
• Case definitions for inclusion and analysis of endpoints in clinical trials for nonalcoholic steatohepatitis through the lens of regulatory science

  2017cited by this paper
• Non-alcoholic fatty liver disease in women with polycystic ovary syndrome: systematic review and meta-analysis

  2017cited by this paper
• Effects of Probiotics on Nonalcoholic Fatty Liver Disease in Obese Children and Adolescents

  2017cited by this paper
• Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling

  2017cited by this paper
• The relationship between non-alcoholic fatty liver disease and small intestinal bacterial overgrowth among overweight and obese children and adolescents

  2017cited by this paper
• NASPGHAN Clinical Practice Guideline for the Diagnosis and Treatment of Nonalcoholic Fatty Liver Disease in Children: Recommendations from the Expert Committee on NAFLD (ECON) and the North American Society of Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN)

  2017cited by this paper
• Comparison of Controlled Attenuation Parameter and Liver Biopsy to Assess Hepatic Steatosis in Pediatric Patients.

  2016cited by this paper
• The severity of nonalcoholic fatty liver disease is associated with gut dysbiosis and shift in the metabolic function of the gut microbiota

  2016cited by this paper
• TM6SF2 Glu167Lys polymorphism is associated with low levels of LDL‐cholesterol and increased liver injury in obese children

  2016cited by this paper
• Comparison of magnetic resonance spectroscopy, proton density fat fraction and histological analysis in the quantification of liver steatosis in children and adolescents

  2016cited by this paper
• Metabolic profiling of fatty liver in young and middle‐aged adults: Cross‐sectional and prospective analyses of the Young Finns Study

  2016cited by this paper
• Bile acids and nonalcoholic fatty liver disease: Molecular insights and therapeutic perspectives

  2016cited by this paper
• More Frequent Clinic Visits Are Associated with Improved Outcomes for Children with NAFLD

  2016cited by this paper
• Role of TM6SF2 rs58542926 in the pathogenesis of nonalcoholic pediatric fatty liver disease: A multiethnic study

  2016cited by this paper
• Nonalcoholic fatty liver disease and obstructive sleep apnea.

  2016cited by this paper
• In Children With Nonalcoholic Fatty Liver Disease, Cysteamine Bitartrate Delayed Release Improves Liver Enzymes but Does Not Reduce Disease Activity Scores.

  2016cited by this paper
• Portal inflammation is independently associated with fibrosis and metabolic syndrome in pediatric nonalcoholic fatty liver disease

  2016cited by this paper
• Lifestyle Interventions Including Nutrition, Exercise, and Supplements for Nonalcoholic Fatty Liver Disease in Children

  2016cited by this paper
• Bile Acids and Dysbiosis in Non-Alcoholic Fatty Liver Disease

  2016cited by this paper
• Prevalence of Prediabetes and Type 2 Diabetes in Children With Nonalcoholic Fatty Liver Disease.

  2016cited by this paper
• Plasma Cytokeratin-18 Level As a Novel Biomarker for Liver Fibrosis in Children With Nonalcoholic Fatty Liver Disease

  2016cited by this paper
• Nocturnal hypoxia-induced oxidative stress promotes progression of pediatric non-alcoholic fatty liver disease.

  2016cited by this paper
• Adipose Tissue Dysfunction and Altered Systemic Amino Acid Metabolism Are Associated with Non-Alcoholic Fatty Liver Disease

  2015cited by this paper
• A double-blind, placebo-controlled randomized trial to evaluate the efficacy of docosahexaenoic acid supplementation on hepatic fat and associated cardiovascular risk factors in overweight children with nonalcoholic fatty liver disease.

  2015cited by this paper
• Altered Bile Acid Metabolome in Patients with Nonalcoholic Steatohepatitis

  2015cited by this paper
• NAFLD: a multisystem disease.

  2015cited by this paper
• Fibrosis progression in nonalcoholic fatty liver vs nonalcoholic steatohepatitis: a systematic review and meta-analysis of paired-biopsy studies.

  2015cited by this paper
• Hepatic De Novo Lipogenesis in Obese Youth Is Modulated by a Common Variant in the GCKR Gene.

  2015cited by this paper
• Liver Fibrosis, but No Other Histologic Features, Is Associated With Long-term Outcomes of Patients With Nonalcoholic Fatty Liver Disease.

  2015cited by this paper
• Effect of a High-Fructose Weight-Maintaining Diet on Lipogenesis and Liver Fat.

  2015cited by this paper
• Magnetic resonance imaging and liver histology as biomarkers of hepatic steatosis in children with nonalcoholic fatty liver disease

  2015cited by this paper
• Heritability of Hepatic Fibrosis and Steatosis Based on a Prospective Twin Study.

  2015cited by this paper
• A Comprehensive Review of Noninvasive Liver Fibrosis Tests in Pediatric Nonalcoholic Fatty Liver Disease

  2015cited by this paper
• Adjunct Prednisone Therapy for Patients with Community-acquired Pneumonia : a Multicenter , Double-blind , Randomized , Placebo-controlled Trial

  2015cited by this paper
• The Development of the Pediatric NAFLD Fibrosis Score (PNFS) to Predict the Presence of Advanced Fibrosis in Children with Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• Influence of dietary pattern, physical activity, and I148M PNPLA3 on steatosis severity in at-risk adolescents

  2014cited by this paper
• Glucokinase Regulatory Protein Gene Polymorphism Affects Liver Fibrosis in Non-Alcoholic Fatty Liver Disease

  2014cited by this paper
• Randomised clinical trial: the beneficial effects of VSL#3 in obese children with non‐alcoholic steatohepatitis

  2014cited by this paper
• TM6SF2 rs58542926 influences hepatic fibrosis progression in patients with non-alcoholic fatty liver disease

  2014cited by this paper
• Estrogen signaling prevents diet-induced hepatic insulin resistance in male mice with obesity.

  2014cited by this paper
• Developmental origins of nonalcoholic fatty liver disease

  2014cited by this paper
• Longitudinal Assessment of High Blood Pressure in Children with Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• Fructose Induced Endotoxemia in Pediatric Nonalcoholic Fatty Liver Disease

  2014cited by this paper
• Bisphenol A and cardiometabolic risk factors in obese children.

  2014cited by this paper
• Shear Wave Elastography in the Evaluation of Liver Fibrosis in Children

  2014cited by this paper
• Accelerated infant weight gain and risk for nonalcoholic fatty liver disease in early adulthood.

  2014cited by this paper
• Relationship between changes in serum levels of keratin 18 and changes in liver histology in children and adults with nonalcoholic fatty liver disease.

  2014cited by this paper
• Use of magnetic resonance elastography to assess hepatic fibrosis in children with chronic liver disease.

  2014cited by this paper
• Histological abnormalities in children with nonalcoholic fatty liver disease and normal or mildly elevated alanine aminotransferase levels.

  2014cited by this paper
• Obstructive sleep apnea and hypoxemia are associated with advanced liver histology in pediatric nonalcoholic fatty liver disease.

  2014cited by this paper

• Clinically distinct metabotypes of pediatric MASLD identified through unsupervised clustering of NASH CRN data.

  2026cites this paper
• Endocrine-liver bidirectional regulation: From mechanistic research to multidisciplinary clinical practice

  2026cites this paper
• A bio-fortified whole tomato food supplement as potential dietary tool for the management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD).

  2026cites this paper
• Metabolic dysfunction–associated steatotic liver disease and pregnancy

  2025cites this paper
• Cornus officinalis Extract Ameliorates Fructose‐Induced Hepatic Steatosis in Mice by Sustaining the Homeostasis of Intestinal Microecology and Lipid Metabolism

  2025cites this paper
• A Guinea Pig Model of Pediatric Metabolic Dysfunction-Associated Steatohepatitis: Poor Vitamin C Status May Advance Disease

  2025cites this paper
• Early and long-term effects of maternal protein restriction on offspring organs and systems: insights from the developmental origins of health and disease (DOHaD)

  2025cites this paper
• The trend in incidence of non-alcoholic fatty liver disease and its impact on cirrhosis and liver cancer: An analysis from Global Burden of Disease 2021.

  2025cites this paper
• Maternal protein restriction compromises hepatic phenotype and antioxidant defense in postweaning male rats, while females exhibit resilience.

  2025cites this paper
• Sex and gender differences in MASLD: pathophysiological mechanisms, clinical implications, and future directions

  2025cites this paper
• Metabolic Dysfunction‐Associated Steatotic Liver Disease (MASLD): Mechanisms, Clinical Implications and Therapeutic Advances

  2025cites this paper
• Gut microbial tyramine facilitates intestinal damage and metabolic dysfunction-associated steatotic liver disease development

  2025cites this paper
• Survey of physicians' knowledge about pediatric nonalcoholic fatty liver disease in China

  2024cites this paper
• Clinical research of fibroscan ‒ TE-CAP at noninvasive diagnosis of hepatic steatosis in children

  2024cites this paper
• Controlled attenuation parameter (CAP): the clinical value based on MRI-PDFF in children with obesity

  2024cites this paper
• Association of Antenatal Gender Preference with Perceived Stress among Pregnant Women

  2024cites this paper
• Editorial: Pediatric obesity: how to diverge from developmental pathways?

  2024cites this paper
• Metabolic Dysfunction–Associated Fatty Liver Disease (MAFLD) and Thyroid Function in Childhood Obesity: A Vicious Circle?

  2024cites this paper
• The epidemiological characteristics of liver disease in hospitalized children: a 10-year single-center retrospective study

  2024cites this paper
• The effects of weight loss interventions on children and adolescents with non‐alcoholic fatty liver disease: A systematic review and meta‐analysis

  2024cites this paper
• Adrenarche-accompanied rise of adrenal sex steroid precursors prevents NAFLD in Young Female rats by converting into active androgens and inactivating hepatic Srebf1 signaling

  2024cites this paper
• Fasting intact insulin by mass spectrometry is associated with metabolic dysfunction–associated steatotic liver disease in youth

  2024influential citation
• Strategic interventions in clinical randomized trials for metabolic dysfunction-associated steatotic liver disease (MASLD) and obesity in the pediatric population: a systematic review with meta-analysis and bibliometric analysis

  2024cites this paper
• A significant and persistent rise in the global burden of adolescent NAFLD and NASH estimated by BMI

  2024cites this paper
• Cardiometabolic risk in children and adolescents with obesity: a position paper of the Italian Society for Pediatric Endocrinology and Diabetology

  2024cites this paper
• Drug-target Mendelian randomisation applied to metabolic dysfunction-associated steatotic liver disease: opportunities and challenges

  2024cites this paper
• Cell-specific regulation of insulin action and hepatic fibrosis by CEACAM1

  2024cites this paper
• Assessing the efficacy of tocotrienol-rich fraction vitamin E in obese children with non-alcoholic fatty liver disease: a single-blind, randomized clinical trial

  2024cites this paper
• Association between non-alcoholic fatty liver disease and metabolic abnormalities in children with different weight statuses.

  2024cites this paper
• Efficacy of Ultrasound for the Detection of Possible Fatty Liver Disease in Children

  2024cites this paper
• Establish a noninvasive model to screen metabolic dysfunction-associated steatotic liver disease in children aged 6–14 years in China and its applications in high-obesity-risk countries and regions

  2024cites this paper
• Swept up in the tsunami: Pediatric and adolescent steatotic (fatty) liver disease.

  2024cites this paper
• Lipidome Changes Associated with a Diet-Induced Reduction in Hepatic Fat among Adolescent Boys with Metabolic Dysfunction-Associated Steatotic Liver Disease

  2024cites this paper
• Lifestyle intervention in children with obesity and nonalcoholic fatty liver disease (NAFLD): study protocol for a randomized controlled trial in Ningbo city (the SCIENT study)

  2024cites this paper
• Prevalence of incidental sonographic findings of hepatic steatosis in children under 4 years of age

  2023cites this paper
• Long-Chain Polyunsaturated Fatty Acids Effects on Cardiovascular Risk in Childhood: A Narrative Review

  2023cites this paper
• The efficacy of L-carnitine in patients with nonalcoholic steatohepatitis and concomitant obesity

  2023cites this paper
• Emerging trends and hotspots in metabolic dysfunction-associated fatty liver disease (MAFLD) research from 2012 to 2021: A bibliometric analysis

  2023cites this paper
• The Role of Vitamin D in Obese Children with Non-Alcoholic Fatty Liver Disease and Associated Metabolic Syndrome

  2023influential citation
• Early-life exposure to gestational diabetes mellitus predisposes offspring to pediatric nonalcoholic fatty liver disease.

  2023cites this paper
• Nutrition assessment and MASH severity in children using the Healthy Eating Index

  2023cites this paper
• Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics

  2022cites this paper
• Magnetic Resonance Imaging-Proton Density Fat Fraction vs. Transient Elastography-Controlled Attenuation Parameter in Diagnosing Non-alcoholic Fatty Liver Disease in Children and Adolescents: A Meta-Analysis of Diagnostic Accuracy

  2022cites this paper
• Effects of Different Doses of Exercise on Inflammation Markers Among Adolescents With Overweight/Obesity: HEPAFIT Study

  2022cites this paper
• Controlled attenuation parameter in the diagnosis of different liver steatosis groups in children with obesity

  2022cites this paper
• Association between urinary cadmium concentrations and liver function in adolescents

  2022cites this paper
• Comparison of the lipidomic signature of fatty liver in children and adults: a cross-sectional study

  2022cites this paper
• Variation in Alanine Aminotransferase in Children with Non-Alcoholic Fatty Liver Disease

  2022cites this paper
• Paediatric non-alcoholic fatty liver disease: an approach to pathological evaluation

  2022cites this paper
• Phospholipids in non-alcoholic fatty liver disease

  2022cites this paper
• Pregnancy and Metabolic-associated Fatty Liver Disease: A Clinical Update

  2022cites this paper
• The Many Names of Fatty Liver Disease: Strengths and Limitations of Metabolic (Dysfunction)-Associated Fatty Liver Disease

  2022cites this paper
• The Role of Macronutrients in the Pathogenesis, Prevention and Treatment of Non-Alcoholic Fatty Liver Disease (NAFLD) in the Paediatric Population—A Review

  2022cites this paper
• Exploring Ganweikang Tablet as a Candidate Drug for NAFLD Through Network Pharmacology Analysis and Experimental Validation

  2022cites this paper
• Transient Elastography Measures of Hepatic Steatosis and Fibrosis Are Associated With Body Composition Among US Adolescents

  2022cites this paper
• Effect of Metformin or Vitamin E on Ultrasonographic Grade and Biochemical Findings of Children and Adolescents with Nonalcoholic Fatty Liver Disease: A Randomized Clinical Trial

  2022cites this paper
• Developing a New qFIBS Model Assessing Histological Features in Pediatric Patients With Non-alcoholic Steatohepatitis

  2022cites this paper
• Performance of Imaging Techniques in Non-invasive Diagnosis of Non-alcoholic Fatty Liver Disease in Children: A Systematic Review and Meta-Analysis

  2022cites this paper
• Clinical spectrum transition and prediction model of nonalcoholic fatty liver disease in children with obesity

  2022cites this paper
• Combination Treatment with Hydroxytyrosol and Vitamin E Improves NAFLD-Related Fibrosis

  2022cites this paper
• Association of Metabolic Signatures with Nonalcoholic Fatty Liver Disease in Pediatric Population

  2022cites this paper
• Prevalence of fatty liver and its related factors in children

  2022cites this paper
• Cardiovascular disease risk in paediatric and young adult non-alcoholic fatty liver disease

  2022cites this paper
• The Efficacy of Using Liraglutide for Improving Non-Acoholic Fatty Liver Disease Condition in Pediatric-Adolescent Population with Obesity: Real World Evidence

  2022cites this paper
• The relationship of Megamonas species with nonalcoholic fatty liver disease in children and adolescents revealed by metagenomics of gut microbiota

  2022cites this paper
• Non-alcoholic Steatohepatitis: Global Impact and Clinical Consequences

  2022cites this paper
• The Role of FXR-Signaling Variability in the Development and Course of Non-Alcoholic Fatty Liver Disease in Children.

  2022cites this paper
• Association of maternal obesity and gestational diabetes mellitus with overweight/obesity and fatty liver risk in offspring

  2022cites this paper
• Tackling Nonalcoholic Fatty Liver Disease: Three Targeted Populations

  2021cites this paper
• Predictors for incidence and remission of nonalcoholic fatty liver disease in obese children and adolescents.

  2021cites this paper
• Plasma lipidomics identifies a signature of 1 NAFLD in children that couples with 2 cardiometabolic outcomes in adults. 3

  2021cites this paper
• Fatty Liver through the Ages- Non-Alcoholic Steatohepatitis (NASH).

  2021cites this paper
• MDG, an Ophiopogon japonicus polysaccharide, inhibits non-alcoholic fatty liver disease by regulating the abundance of Akkermansia muciniphila.

  2021cites this paper
• The effects of Mediterranean diet on hepatic steatosis, oxidative stress, and inflammation in adolescents with non‐alcoholic fatty liver disease: A randomized controlled trial

  2021cites this paper
• Relationship between nonalcoholic fatty liver disease and chronic kidney disease could start in childhood

  2021cites this paper
• The burden and sexual dimorphism with nonalcoholic fatty liver disease in Asian children: A systematic review and meta‐analysis

  2021cites this paper
• RNA Splicing: A Versatile Regulatory Mechanism in Pediatric Liver Diseases

  2021cites this paper
• Hepatic Steatosis in Infancy: The Beginning of Pediatric Nonalcoholic Fatty Liver Disease?

  2021cites this paper
• Nonalcoholic Fatty Liver Disease in Children with Obesity: Narrative Review and Research Gaps

  2021cites this paper
• Advances in paediatric nonalcoholic fatty liver disease: Role of lipidomics

  2021cites this paper
• Cinnamic Acid Ameliorates Nonalcoholic Fatty Liver Disease by Suppressing Hepatic Lipogenesis and Promoting Fatty Acid Oxidation

  2021cites this paper
• Hepatic fat in early childhood is independently associated with estimated insulin resistance: The Healthy Start Study.

  2021cites this paper
• Non-alcoholic fatty liver disease in children and young adults is associated with increased long-term mortality.

  2021cites this paper
• Pediatric nonalcoholic fatty liver disease – a changing diagnostic paradigm

  2021cites this paper
• Nonalcoholic Fatty Liver Disease (NAFLD) Association with Pediatric Diabetes

  2021cites this paper
• NAFLD and renal function in children: is there a genetic link?

  2021cites this paper
• Food Insecurity, Race, and Adolescent Non-Alcoholic Fatty Liver disease in NHANES 2001-06

  2020cites this paper
• Plasma lipidomics distinguishes NASH and fibrosis from simple fatty liver in children

  2020cites this paper
• The relationship between excessive dietary fructose consumption and paediatric fatty liver disease

  2020cites this paper
• New Perspectives on Genetic Prediction for Pediatric Metabolic Associated Fatty Liver Disease

  2020cites this paper
• Intestinal permeability in human nonalcoholic fatty liver disease: A systematic review and meta‐analysis

  2020cites this paper
• Effect of recombinant human growth hormone on liver fat content in young adults with nonalcoholic fatty liver disease

  2020cites this paper
• Effects of Dietary and Lifestyle Interventions on Liver, Clinical and Metabolic Parameters in Children and Adolescents with Non-Alcoholic Fatty Liver Disease: A Systematic Review

  2020cites this paper
• Serum proteome assessment in nonalcoholic fatty liver disease in children: a preliminary study

  2020cites this paper
• Sex Hormone Relations to Histologic Severity of Pediatric Nonalcoholic Fatty Liver Disease.

  2020cites this paper
• History of Nonalcoholic Fatty Liver Disease

  2020cites this paper
• Peroxisome Proliferator-Activated Receptors and Their Novel Ligands as Candidates for the Treatment of Non-Alcoholic Fatty Liver Disease

  2020cites this paper
• World Journal of Gastroenterology

  year unknowncites this paper